These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25414415)

  • 1. Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV.
    Cone RA
    J Infect Dis; 2014 Dec; 210 Suppl 3(Suppl 3):S616-21. PubMed ID: 25414415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid.
    Tyssen D; Wang YY; Hayward JA; Agius PA; DeLong K; Aldunate M; Ravel J; Moench TR; Cone RA; Tachedjian G
    mSphere; 2018 Jul; 3(4):. PubMed ID: 29976641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human vaginal microbial community.
    Vaneechoutte M
    Res Microbiol; 2017; 168(9-10):811-825. PubMed ID: 28851670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of high-risk sexual behaviour with diversity of the vaginal microbiota and abundance of Lactobacillus.
    Wessels JM; Lajoie J; Vitali D; Omollo K; Kimani J; Oyugi J; Cheruiyot J; Kimani M; Mungai JN; Akolo M; Stearns JC; Surette MG; Fowke KR; Kaushic C
    PLoS One; 2017; 12(11):e0187612. PubMed ID: 29095928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal microbiota and viral sexually transmitted diseases.
    Nardis C; Mosca L; Mastromarino P
    Ann Ig; 2013; 25(5):443-56. PubMed ID: 24048183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The barrier to HIV transmission provided by genital tract Lactobacillus colonization.
    Mirmonsef P; Spear GT
    Am J Reprod Immunol; 2014 Jun; 71(6):531-6. PubMed ID: 24661438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression.
    Delgado-Diaz DJ; Jesaveluk B; Hayward JA; Tyssen D; Alisoltani A; Potgieter M; Bell L; Ross E; Iranzadeh A; Allali I; Dabee S; Barnabas S; Gamieldien H; Blackburn JM; Mulder N; Smith SB; Edwards VL; Burgener AD; Bekker LG; Ravel J; Passmore JS; Masson L; Hearps AC; Tachedjian G
    Microbiome; 2022 Aug; 10(1):141. PubMed ID: 36045402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota.
    O'Hanlon DE; Moench TR; Cone RA
    PLoS One; 2013; 8(11):e80074. PubMed ID: 24223212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections.
    Avitabile E; Menotti L; Croatti V; Giordani B; Parolin C; Vitali B
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal microbiota and its role in HIV transmission and infection.
    Petrova MI; van den Broek M; Balzarini J; Vanderleyden J; Lebeer S
    FEMS Microbiol Rev; 2013 Sep; 37(5):762-92. PubMed ID: 23789590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal pH measured in vivo: lactobacilli determine pH and lactic acid concentration.
    O'Hanlon DE; Come RA; Moench TR
    BMC Microbiol; 2019 Jan; 19(1):13. PubMed ID: 30642259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay among Vaginal Microbiome, Immune Response and Sexually Transmitted Viral Infections.
    Torcia MG
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
    Doerflinger SY; Throop AL; Herbst-Kralovetz MM
    J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of vaginal infections.
    AIDS Patient Care STDS; 1999 Aug; 13(8):505. PubMed ID: 10800533
    [No Abstract]   [Full Text] [Related]  

  • 15. Medroxyprogesterone acetate alters the vaginal microbiota and microenvironment in women and increases susceptibility to HIV-1 in humanized mice.
    Wessels JM; Lajoie J; Cooper MIJH; Omollo K; Felker AM; Vitali D; Dupont HA; Nguyen PV; Mueller K; Vahedi F; Kimani J; Oyugi J; Cheruiyot J; Mungai JN; Deshiere A; Tremblay MJ; Mazzulli T; Stearns JC; Ashkar AA; Fowke KR; Surette MG; Kaushic C
    Dis Model Mech; 2019 Oct; 12(10):. PubMed ID: 31537512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
    Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal Microbiota.
    Mendling W
    Adv Exp Med Biol; 2016; 902():83-93. PubMed ID: 27161352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal vaginal flora as a biological risk factor for acquisition of HIV infection and sexually transmitted diseases.
    Schwebke JR
    J Infect Dis; 2005 Oct; 192(8):1315-7. PubMed ID: 16170746
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaginal infections in human immunodeficiency virus-infected women.
    Helfgott A; Eriksen N; Bundrick CM; Lorimor R; Van Eckhout B
    Am J Obstet Gynecol; 2000 Aug; 183(2):347-55. PubMed ID: 10942468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vaginal microbiome and sexually transmitted infections are interlinked: Consequences for treatment and prevention.
    van de Wijgert JHHM
    PLoS Med; 2017 Dec; 14(12):e1002478. PubMed ID: 29281632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.